Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does DENOSUMAB Cause Bone density abnormal? 643 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 643 reports of Bone density abnormal have been filed in association with DENOSUMAB (Bilprevda). This represents 0.4% of all adverse event reports for DENOSUMAB.

643
Reports of Bone density abnormal with DENOSUMAB
0.4%
of all DENOSUMAB reports
0
Deaths
17
Hospitalizations

How Dangerous Is Bone density abnormal From DENOSUMAB?

Of the 643 reports, 17 (2.6%) required hospitalization, and 1 (0.2%) were considered life-threatening.

Is Bone density abnormal Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 643 reports have been filed with the FAERS database.

What Other Side Effects Does DENOSUMAB Cause?

Off label use (34,612) Death (16,545) Osteonecrosis of jaw (8,438) Arthralgia (5,890) Pain in extremity (4,541) Back pain (4,465) Pain (4,102) Product storage error (3,621) Fall (3,322) Fatigue (3,009)

What Other Drugs Cause Bone density abnormal?

EMTRICITABINE\TENOFOVIR DISOPROXIL (1,039) EFAVIRENZ\EMTRICITABINE\TENOFOVIR DISOPROXIL (580) ROMOSOZUMAB-AQQG (454) TENOFOVIR DISOPROXIL (310) COBICISTAT\ELVITEGRAVIR\EMTRICITABINE\TENOFOVIR DISOPROXIL (276) EMTRICITABINE\RILPIVIRINE\TENOFOVIR DISOPROXIL (199) ADALIMUMAB (174) METHOTREXATE (155) TERIPARATIDE (146) ETANERCEPT (145)

Which DENOSUMAB Alternatives Have Lower Bone density abnormal Risk?

DENOSUMAB vs DEOXYCHOLIC ACID DENOSUMAB vs DEPAKINE CHRONO DENOSUMAB vs DEPAKOTE DENOSUMAB vs DEPO-PROVERA DENOSUMAB vs DERMATOPHAGOIDES FARINAE

Related Pages

DENOSUMAB Full Profile All Bone density abnormal Reports All Drugs Causing Bone density abnormal DENOSUMAB Demographics